Perceptions of Modulatory Factors in Migraine and Epilepsy: A Multicenter Study

Emel Ur Özçelik1, Katia Lin2, Ruta Mameniškienè3

  • 1Departments of Neurology and Clinical Neurophysiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Insights

Patients with migraine and epilepsy frequently identify modulatory factors (MFs) that trigger or inhibit their episodes. Migraine patients reported MFs more often than epilepsy patients, with emotional stress and lack of sleep being common triggers for both. Understanding these factors can aid in managing both conditions.

Area of Science:

  • Neurology
  • Epileptology
  • Headache Medicine

Background:

  • Migraine and epilepsy are common episodic neurological disorders.
  • Both conditions can be influenced by modulatory factors (MFs) that precipitate or inhibit attacks.
  • Self-perception of MFs may differ between patients with migraine (PWM) and patients with epilepsy (PWE).

Purpose of the Study:

  • To compare the self-perception of MFs in PWM and PWE.
  • To utilize a standardized protocol across multiple countries for this comparison.
  • To investigate potential transcultural differences in MF identification.

Main Methods:

  • A transcultural, multicenter, comparative, cross-sectional study design was employed.
  • Patients meeting International Classification of Headache Disorders 3rd edition (ICHD-3) for migraine and International League Against Epilepsy (ILAE) criteria for epilepsy were included.
  • A semi-structured questionnaire was used to collect data on clinical, epidemiological, and perceived MFs.

Main Results:

  • 608 individuals were surveyed across five university centers in Brazil, Guatemala, Lithuania, and Turkey.
  • A high percentage of both PWM (91.6%) and PWE (82.7%) identified precipitating factors (PFs).
  • Emotional stress and lack of sleep were the most frequent PFs for both groups, though more prevalent in PWM. Inhibitory factors (IFs) were also reported, with 'darkness' common in PWM and 'positive feelings' in PWE.

Conclusions:

  • This study provides the first investigation using a standardized questionnaire on MFs for both migraine and epilepsy attacks across different countries.
  • MFs are frequently recognized in both patient cohorts, with a higher prevalence in migraine.
  • Identifying self-perceived MFs can be a valuable tool for managing both migraine and epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
565
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
839
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
562
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
858
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
626